Table 2.
Vγ9 day 0 | Vγ9 day 8 | Vδ2 day 0 | Vδ2 day 8 | CD4 day 0 | CD4 day 8 | CD8 day 0 | CD8 day 8 | |
Controls | 84.71 ± 3.12** | 92.85 ± 1.70 | 77.67 ± 3.8* | 89.46 ± 3.43 | 2.03 ± 0.93 | 0.76 ± 0.65 | 11.92 ± 2.55 | 10.13 ± 1.91 |
CFw | 89.83 ± 2.78* | 94.75 ± 2.06 | 84.65 ± 3.89* | 92.39 ± 3.23 | 0.49 ± 0.26 | 0.27 ± 0.18 | 9.21 ± 1.17 | 10.13 ± 1.91 |
CFp | 92.52 ± 1.40** | 96.82 ± 1.14 | 85.90 ± 3.88** | 94.44 ± 2.72 | 0.78 ± 0.37 | 0.54 ± 0.31 | 9.48 ± 1.80 | 9.84 ± 2.69 |
CFn | 82.80 ± 8.8 | 87.45 ± 7.98 | 79.46 ± 10.32 | 87.32 ± 8.64 | 0.1 ± 0.01 | 0.1 ± 0.01 | 8.41 ± 1.53 | 11.28 ± 3.42 |
Results are expressed as the percentage of positive cells (mean ± s.e.m.) in the γδ T subpopulation. CFw (cystic fibrosis patients, n = 14), CFp (cystic fibrosis patients infected by PA, n = 8), CFn (cystic fibrosis patients without PA, n = 4). Means comparison between paired samples (days 0 and 8) were made by the Student's t test: *Significantly lower than the value at day 8: p < 0.01 **Significantly lower than the value at day 8: p < 0.05